{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:51:20Z","timestamp":1793911880378,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajkd.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1053\/j.ajkd.2018.06.013","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T23:13:58Z","timestamp":1535066038000},"page":"857-865","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Emerging Concepts in Hematopoietic Stem Cell Transplantation\u2013Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments"],"prefix":"10.1053","volume":"72","author":[{"given":"Rimda","family":"Wanchoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruthee L.","family":"Bayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Bassil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenar D.","family":"Jhaveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.ajkd.2018.06.013_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/1076029615598221","article-title":"Hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"22","author":"Elsallabi","year":"2016","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.013_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2215\/CJN.02070508","article-title":"Renal thrombotic microangiopathy after hematopoietic stem cell transplantation, role of GVHD in\u00a0the pathogenesis","volume":"4","author":"Changsirikulchai","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.013_bib3","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/01.tp.0000297998.33418.7e","article-title":"Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study","volume":"85","author":"Siami","year":"2008","journal-title":"Transplantation"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.013_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1440-1797.2007.00915.x","article-title":"Clinicopathologic analysis of renal biopsies after HSCT","volume":"13","author":"Chan","year":"2008","journal-title":"Nephrology"},{"issue":"8","key":"10.1053\/j.ajkd.2018.06.013_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.bmt.1705758","article-title":"Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?","volume":"40","author":"Batts","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.013_bib6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/00003495-200969020-00004","article-title":"TMA in HSCT, diagnosis and treatment","volume":"69","author":"Choi","year":"2009","journal-title":"Drugs"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.013_bib7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A\u00a0new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.013_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbmt.2009.11.018","article-title":"Hypertension in long-term survivors of pediatric hematopoietic cell transplantation","volume":"16","author":"Hoffmeister","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.013_bib9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3324\/haematol.10699","article-title":"Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an international working group","volume":"92","author":"Ruutu","year":"2007","journal-title":"Hematologica"},{"issue":"8","key":"10.1053\/j.ajkd.2018.06.013_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.bbmt.2005.06.001","article-title":"Blood and Marrow Transplant Clinical Trials Network Toxicity Committee consensus summary: thrombotic microangiopathy after hematopoietic stem cell transplantation","volume":"11","author":"Ho","year":"2005","journal-title":"Biol Bone Marrow Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.013_bib11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.ajkd.2018.06.013_bib12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","article-title":"Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"90","author":"Cho","year":"2010","journal-title":"Transplantation"},{"issue":"6","key":"10.1053\/j.ajkd.2018.06.013_bib13","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1182\/blood-2011-02-321315","article-title":"Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"118","author":"Laskin","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2018.06.013_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1537-2995.2004.00700.x","article-title":"Thrombotic thrombocytopenic purpura","volume":"44","author":"George","year":"2004","journal-title":"Transfusion"},{"key":"10.1053\/j.ajkd.2018.06.013_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/bmt.2014.17","article-title":"Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus","volume":"49","author":"Labrador","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2018.06.013_bib16","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2215\/CJN.10630917","article-title":"Changes in glomerular filtration rate and impact on long-term survival among adults after hematopoietic cell transplantation: a prospective cohort study","volume":"13","author":"Hingorani","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.013_bib17","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hon.2310","article-title":"Risk and prognostic factors of transplantation-associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study","volume":"35","author":"Ye","year":"2017","journal-title":"Hematol Oncol"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.013_bib18","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/1060028015593369","article-title":"Transplantation-associated thrombotic microangiopathy in patients treated with sirolimus and cyclosporine as salvage therapy for graft-versus-host disease","volume":"49","author":"Garc\u00eda-Mart\u00edn","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.ajkd.2018.06.013_bib19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/01.tp.0000230373.82376.46","article-title":"Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Uderzo","year":"2006","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2018.06.013_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1473-0502(02)00020-4","article-title":"Transplantation-associated thrombotic microangiopathy is associated with transplantation from unrelated donors, acute graft-versus-host disease and venoocclusive disease of the liver","volume":"27","author":"Daly","year":"2002","journal-title":"Transfus Apher Sci"},{"key":"10.1053\/j.ajkd.2018.06.013_bib21","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bbmt.2004.03.002","article-title":"Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced","volume":"10","author":"Shimoni","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1046\/j.1537-2995.2003.00282.x","article-title":"Thrombotic microangiopathy in blood and marrow transplant patients receiving tacrolimus or cyclosporine A","volume":"43","author":"Sarkodee-Adoo","year":"2003","journal-title":"Transfusion"},{"issue":"7","key":"10.1053\/j.ajkd.2018.06.013_bib23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.bbmt.2010.02.006","article-title":"Chronic kidney disease, thrombotic microangiopathy and hypertension following T cell depleted hematopoietic stem cell transplantation","volume":"16","author":"Glezerman","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib25","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.2005.05616.x","article-title":"Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft versus-host disease","volume":"130","author":"Couriel","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1053\/j.ajkd.2018.06.013_bib26","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1182\/blood-2013-05-501445","article-title":"Abnormalities in the alternative pathway of complement in children with hematopoietic stem cell transplant-associated thrombotic microangiopathy","volume":"122","author":"Jodele","year":"2013","journal-title":"Blood"},{"issue":"17","key":"10.1053\/j.ajkd.2018.06.013_bib27","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Norris","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.013_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00467-010-1556-4","article-title":"aHUS caused by complement dysregulation: new therapies on the horizon","volume":"26","author":"Waters","year":"2011","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2018.06.013_bib29","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1172\/JCI86418","article-title":"VEGF regulates local inhibitory complement proteins in the eye and kidney","volume":"127","author":"Keir","year":"2017","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1053\/j.ajkd.2018.06.013_bib30","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.bbmt.2005.07.012","article-title":"Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children","volume":"11","author":"Hale","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.013_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood-2009-05-221549","article-title":"Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome","volume":"115","author":"Moore","year":"2010","journal-title":"Blood"},{"issue":"20","key":"10.1053\/j.ajkd.2018.06.013_bib32","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1182\/bloodadvances.2017008250","article-title":"In\u00a0vitro evidence of complement activation in transplantation associated thrombotic microangiopathy","volume":"1","author":"Rotz","year":"2017","journal-title":"Blood Adv"},{"key":"10.1053\/j.ajkd.2018.06.013_bib33","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00277-017-3092-9","article-title":"Plasma levels of complement activation fragments of C3b and sC5b-9 significantly increased in patients with thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"96","author":"Qi","year":"2017","journal-title":"Ann Hematol"},{"key":"10.1053\/j.ajkd.2018.06.013_bib34","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib35","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/modpathol.2008.152","article-title":"Clinical significant of the distribution of C4d deposits in the different anatomic compartments of the allograft kidney","volume":"21","author":"Batal","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1053\/j.ajkd.2018.06.013_bib36","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.2007010073","article-title":"Antibody mediated renal allograft rejection: diagnosis and pathogenesis","volume":"18","author":"Colvin","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.013_bib37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31829807aa","article-title":"Renal arteriolar C4d deposition. A novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"96","author":"Laskin","year":"2013","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.013_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft versus host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.013_bib39","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.beha.2008.02.002","article-title":"Vascular endothelium as \u2018novel\u2019 target of graft versus host disease","volume":"21","author":"Tichelli","year":"2008","journal-title":"Best Pract Res Clin Hematol"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.013_bib40","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ekir.2017.12.013","article-title":"Renal thrombotic microangiopathy after hematopoietic stem cell transplantation: involvement of chronic graft versus-host disease","volume":"3","author":"Mii","year":"2018","journal-title":"Kidney Int Rep"},{"key":"10.1053\/j.ajkd.2018.06.013_bib41","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1016\/S0140-6736(02)08907-9","article-title":"Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease","volume":"359","author":"Biedermann","year":"2002","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2018.06.013_bib42","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.bmt.1701151","article-title":"Diagnostic value of hemostatic parameters in bone marrow transplant-associated thrombotic microangiopathy","volume":"21","author":"Kanamori","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib43","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/sj.bmt.1703026","article-title":"Serum levels of soluble adhesion molecules in stem cell transplantation-related complications","volume":"27","author":"Matsuda","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib44","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2018.06.013_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.bmt.1705410","article-title":"Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation","volume":"38","author":"Min","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMoa1213299","article-title":"ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death","volume":"369","author":"Vander Lugt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2018.06.013_bib47","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMc1700185","article-title":"ST2 and endothelial injury as a link between GVHD and microangiopathy","volume":"376","author":"Rotz","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2018.06.013_bib48","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","article-title":"Steroid refractory GVHD: T cell attack within a vulnerable endothelial system","volume":"118","author":"Luft","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2018.06.013_bib49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bbmt.2012.09.018","article-title":"Endothelial vulnerability and endothelial damage are associated with risk of graft versus host disease and response to steroid treatment","volume":"19","author":"Dietrich","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"19","key":"10.1053\/j.ajkd.2018.06.013_bib50","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","article-title":"Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogenic stem cell transplantation","author":"Arai","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1053\/j.ajkd.2018.06.013_bib51","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1182\/blood-2017-05-782870","article-title":"Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD","volume":"130","author":"Gloude","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.ajkd.2018.06.013_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115399","article-title":"Acute graft-versus-host disease of the kidney in allogeneic rat bone marrow transplantation","volume":"9","author":"Higo","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.ajkd.2018.06.013_bib53","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2169\/internalmedicine.55.7011","article-title":"Hematopoietic stem cell transplantation nephropathy associated with chronic graft-versus-host disease without extrarenal involvement","volume":"55","author":"Ishida","year":"2016","journal-title":"Intern Med"},{"issue":"3","key":"10.1053\/j.ajkd.2018.06.013_bib54","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.transci.2007.03.004","article-title":"ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathy","volume":"36","author":"Worel","year":"2007","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.013_bib55","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbmt.2006.11.020","article-title":"Transplant-associated microangiopathy in patients receiving tacrolimus following allogeneic stem cell transplantation: risk factors and response to treatment","volume":"13","author":"Oran","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2018.06.013_bib56","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/sj.bmt.1705976","article-title":"Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation","volume":"41","author":"Cho","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1053\/j.ajkd.2018.06.013_bib57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/bmt.2009.230","article-title":"Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning","volume":"45","author":"Willems","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1537-2995.2012.03776.x","article-title":"Does early initiation of therapeutic plasma exchange improve outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?","volume":"53","author":"Jodele","year":"2013","journal-title":"Transfusion"},{"issue":"5","key":"10.1053\/j.ajkd.2018.06.013_bib59","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2141.2007.06588.x","article-title":"Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab","volume":"137","author":"Au","year":"2007","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1053\/j.ajkd.2018.06.013_bib60","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bmt.1705657","article-title":"Life-threatening hemolytic-uremic syndrome treated with rituximab in an allogeneic bone marrow transplant recipient","volume":"39","author":"Ostronoff","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"1292","key":"10.1053\/j.ajkd.2018.06.013_bib61","first-page":"72","article-title":"Successful treatment of transplant-associated microangiopathy with rituximab","volume":"122","author":"Marr","year":"2009","journal-title":"N\u00a0Z Med J"},{"key":"10.1053\/j.ajkd.2018.06.013_bib62","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1744-9987.2011.00978.x","article-title":"Plasmapheresis refractory thrombotic microangiopathy in a hematopoietic stem cell transplant recipient","volume":"15","author":"Vasko","year":"2011","journal-title":"Ther Apher Dial"},{"key":"10.1053\/j.ajkd.2018.06.013_bib63","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.transci.2016.04.007","article-title":"New approaches in the diagnosis, pathophysiology and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"54","author":"Jodele","year":"2016","journal-title":"Trans Apher Sci"},{"issue":"2","key":"10.1053\/j.ajkd.2018.06.013_bib64","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1076029615599439","article-title":"Eculizumab in transplant-associated thrombotic microangiopathy","volume":"23","author":"Dhakal","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1053\/j.ajkd.2018.06.013_bib65","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/bjh.12202","article-title":"Successful use of eculizumab in a patient with post transplant thrombotic microangiopathy","volume":"161","author":"Peffault de Latour","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1053\/j.ajkd.2018.06.013_bib66","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bmt.1703414","article-title":"Defibrotide as a promising treatment for thrombotic thrombocytopenic purpura in patients undergoing bone marrow transplantation [letter]","volume":"29","author":"Corti","year":"2002","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1053\/j.ajkd.2018.06.013_bib67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.ajkd.2018.06.013_bib68","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/1744-9987.12015","article-title":"Plasmapheresis refractory transplantation associated thrombotic microangiopathy successfully treated with pravastatin and limprost alfadex","volume":"17","author":"Uesawa","year":"2013","journal-title":"Ther Apher Dial"},{"key":"10.1053\/j.ajkd.2018.06.013_bib69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jca.2920060104","article-title":"Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome\/thrombotic thrombocytopenic purpura associated with bone marrow transplantation","volume":"6","author":"Silva","year":"1991","journal-title":"J\u00a0Clin Apher"},{"key":"10.1053\/j.ajkd.2018.06.013_bib70","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/01.TP.0000141363.81600.0D","article-title":"Thrombotic microangiopathy after allogenic blood and marrow transplantation is associated with dose intensive myeloablative conditioning regimens, unrelated donors, and methylprednisolone T cell depletion","volume":"78","author":"Hahn","year":"2004","journal-title":"Transplantation"},{"key":"10.1053\/j.ajkd.2018.06.013_bib71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/sj.bmt.1705241","article-title":"Vincristine is an effective therapeutic approach for transplantation associated thrombotic microangiopathy","volume":"37","author":"Mateos","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"10.1053\/j.ajkd.2018.06.013_bib72","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1182\/bloodadvances.2016002832","article-title":"Use of the complement inhibitor Coversin to treat HSCT-associated TMA","volume":"1","author":"Goodship","year":"2017","journal-title":"Blood Adv"},{"key":"10.1053\/j.ajkd.2018.06.013_bib73","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/trf.13437","article-title":"Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin","volume":"56","author":"Fujiwara","year":"2016","journal-title":"Transfusion"},{"issue":"10","key":"10.1053\/j.ajkd.2018.06.013_bib74","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1038\/leu.2015.212","article-title":"Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey","volume":"29","author":"Zeiser","year":"2015","journal-title":"Leukemia"}],"updated-by":[{"DOI":"10.1053\/j.ajkd.2018.11.002","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000}}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618307996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638618307996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T21:37:25Z","timestamp":1571780245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638618307996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":74,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0272638618307996"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.013","relation":{"erratum":[{"id-type":"doi","id":"10.1053\/j.ajkd.2018.11.002","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging Concepts in Hematopoietic Stem Cell Transplantation\u2013Associated Renal Thrombotic Microangiopathy and Prospects for New Treatments","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2018.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}